About EKR Therapeutics
EKR Therapeutics is a company based in Bedminster (United States) founded in 2005 by Cathy Kerzner and Richard DeSimone was acquired by Cornerstone Therapeutics in May 2012. EKR Therapeutics has raised $63 million across 3 funding rounds from investors including Cornerstone Therapeutics, GE Healthcare Equipment Finance and Turmeric Acquisition Corp.
- Headquarter Bedminster, United States
- Founders Cathy Kerzner, Richard DeSimone
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$63 M (USD)
in 3 rounds
-
Latest Funding Round
$50 M (USD), Series C
Mar 10, 2008
-
Investors
Cornerstone Therapeutics
& 6 more
-
Employee Count
Not available
-
Acquired by
Cornerstone Therapeutics
(May 14, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of EKR Therapeutics
EKR Therapeutics has successfully raised a total of $63M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in March 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in EKR Therapeutics
EKR Therapeutics has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Cornerstone Therapeutics, GE Healthcare Equipment Finance and Turmeric Acquisition Corp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm investing in technology and healthcare businesses for growth capital.
|
Locked | Locked | Locked | |
|
Investment firm focusing on lower-middle market growth, healthcare, and various strategies.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for EKR Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EKR Therapeutics
Investment portfolio details for EKR Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - EKR Therapeutics
Detailed financials for EKR Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ekr Therapeutics Comparisons
Peer comparison for EKR Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of EKR Therapeutics
Detailed competitors of EKR Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ekr Therapeutics
Complete news archive for EKR Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EKR Therapeutics
EKR Therapeutics was founded in 2005 and raised its 1st funding round 2 years after it was founded.
EKR Therapeutics is headquartered in Bedminster, United States. It is registered at Bedminster, New Jersey, United States.
John Bailye is the current CEO of EKR Therapeutics.
EKR Therapeutics is a funded company, having raised a total of $63M across 3 funding rounds to date.
EKR Therapeutics was founded in 2005 and is located in Bedminster, United States. Operations in the specialty pharmaceutical sector involve the acquisition, development, and commercialization of prescription products focused on oncology supportive care. Therapeutic areas addressed include oral mucositis, stomatitis, dry mouth, nutritional support, cachexia, skin reactions, bone marrow depression, bone complications, pain management, nausea, vomiting, and diarrhea.
EKR Therapeutics has 7 investors. Key investors include Cornerstone Therapeutics, GE Healthcare Equipment Finance, Turmeric Acquisition Corp, LLR Partners, and NewSpring Capital.